The influence of vascular risk factors and stroke on cognition in late life analysis of the NACC cohort

Alzheimer Disease and Associated Disorders

Volumn 29, Issue 4, 2015, Pages 287-293

  Viswanathan, Anand ^a   Macklin, Eric A ^a   Betensky, Rebecca ^a,b   Hyman, Bradley ^a   Smith, Eric E ^c   Blacker, Deborah ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cerebrovascular disease; Cognitive decline; Cognitively normal; Framingham stroke risk profile; Stroke; Vascular risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN E4;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BOSTON NAMING TEST; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE DEFECT; DEMENTIA; EDUCATION; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; WECHSLER ADULT INTELLIGENCE SCALE; AGE; AGED; ALZHEIMER DISEASE; CEREBROVASCULAR DISORDERS; CLINICAL TRIAL; COGNITION DISORDERS; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; LONGITUDINAL STUDY; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; STROKE; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84948088599     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0000000000000080     Document Type: Article

References (47)

1. Elias MF, Sullivan LM, D'Agostino RB, et al. Framingham stroke risk profile and lowered cognitive performance. Stroke. 2004;35:404-409.
2. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein e, and prevalence of dementia and alzheimer's disease in the rotterdam study. Lancet. 1997;349:151-154.
3. Mielke MM, Rosenberg PB, Tschanz J, et al. Vascular factors predict rate of progression in alzheimer disease. Neurology. 2007;69:1850-1858.
4. Caselli RJ, Dueck AC, Locke DE, et al. Cerebrovascular risk factors and preclinical memory decline in healthy apoe epsilon4 homozygotes. Neurology.76:1078-1084.
5. Li J, Wang YJ, Zhang M, et al. Vascular risk factors promote conversion from mild cognitive impairment to alzheimer disease. Neurology.76:1485-1491.
6. Llewellyn DJ, Lang IA, Xie J, et al. Framingham stroke risk profile and poor cognitive function: a population-based study. BMC Neurol. 2008;8:12.
7. Ott A, Breteler MM, de Bruyne MC, et al. Atrial fibrillation and dementia in a population-based study. The rotterdam study. Stroke. 1997;28:316-321.
8. Luchsinger JA, Tang MX, Stern Y, et al. Diabetes mellitus and risk of alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001;154:635-641.
9. Luchsinger JA, Reitz C, Honig LS, et al. Aggregation of vascular risk factors and risk of incident alzheimer disease. Neurology. 2005;65:545-551.
10. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001;322:1447-1451.
11. Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-1145.
12. Deschaintre Y, Richard F, Leys D, et al. Treatment of vascular risk factors is associated with slower decline in alzheimer disease. Neurology. 2009;73:674-680.
13. Marzona I, O'Donnell M, Teo K, et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ontarget and transcend studies. CMAJ. 2012;184:E329-E336.
14. Xiong GL, Plassman BL, Helms MJ, et al. Vascular risk factors and cognitive decline among elderly male twins. Neurology. 2006;67:1586-1591.
15. Ott A, Stolk RP, van Harskamp F, et al. Diabetes mellitus and the risk of dementia: the rotterdam study. Neurology. 1999; 53:1937-1942.
16. Haring B, Leng X, Robinson J, et al. Cardiovascular disease and cognitive decline in postmenopausal women: results from the women's health initiative memory study. J Am Heart Assoc. 2013;2:e000369.
17. Ott A, Slooter AJ, Hofman A, et al. Smoking and risk of dementia and alzheimer's disease in a population-based cohort study: the rotterdam study. Lancet. 1998;351:1840-1843.
18. D'Agostino RB, Wolf PA, Belanger AJ, et al. Stroke risk profile: adjustment for antihypertensive medication. The framingham study. Stroke. 1994;25:40-43.
19. Wolf PA, D'Agostino RB, Belanger AJ, et al. Probability of stroke: a risk profile from the Framingham study. Stroke. 1991;22:312-318.
20. Knopman DS, Mosley TH, Catellier DJ, et al. Fourteen-year longitudinal study of vascular risk factors, apoe genotype, and cognition: the aric mri study. Alzheimers Dement. 2009;5: 207-214.
21. Blair CK, Folsom AR, Knopman DS, et al. Apoe genotype and cognitive decline in a middle-aged cohort. Neurology. 2005;64:268-276.
22. Unverzagt FW, McClure LA, Wadley VG, et al. Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology. 2011;77:1729-1736.
23. Brady CB, Spiro A III, McGlinchey-Berroth R, et al. Stroke risk predicts verbal fluency decline in healthy older men: Evidence from the normative aging study. J Gerontol. 2001;56:P340-P346.
24. Weintraub S, Salmon D, Mercaldo N, et al. The alzheimer's disease centers' uniform data set (uds): the neuro-psychologic test battery. Alzheimer Dis Assoc Disord. 2009;23: 91-101.
25. Morris JC, Weintraub S, Chui HC, et al. The uniform data set (uds): clinical and cognitive variables and descriptive data from alzheimer disease centers. Alzheimer Dis Assoc Disord. 2006; 20:210-216.
26. Launer LJ, Masaki K, Petrovitch H, et al. The association between midlife blood pressure levels and late-life cognitive function. The honolulu-asia aging study. JAMA. 1995;274: 1846-1851.
27. Carmelli D, Swan GE, Reed T, et al. Midlife cardiovascular risk factors, apoe, and cognitive decline in elderly male twins. Neurology. 1998;50:1580-1585.
28. Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neuro-biol Aging. 2000;21:49-55.
29. Whitmer RA, Sidney S, Selby J, et al. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005; 64:277-281.
30. Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: how to move forward?. Neurology. 2009;72: 368-374.
31. Fitzpatrick AL, Kuller LH, Lopez OL, et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009;66:336-342.
32. Mielke MM, Zandi PP, Shao H, et al. The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology. 2010;75:1888-1895.
33. Power MC, Weuve J, Gagne JJ, et al. The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis. Epidemiology. 2011;22:646-659.
34. Wilson RS, Leurgans SE, Boyle PA, et al. Cognitive decline in prodromal alzheimer disease and mild cognitive impairment. Arch Neurol. 2011;68:351-356.
35. Howieson DB, Carlson NE, Moore MM, et al. Trajectory of mild cognitive impairment onset. J Int Neuropsychol Soc. 2008;14:192-198.
36. Hofman A, Rocca WA, Brayne C, et al. The prevalence of dementia in europe: a collaborative study of 1980-1990 findings. Eurodem prevalence research group. Int J Epidemiol. 1991;20:736-748.
37. Jorm AF, Jolley D. The incidence of dementia: a meta-analysis. Neurology. 1998;51:728-733.
38. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain. 2005;128:2034-2041.
39. Biesbroek JM, Kuijf HJ, van der Graaf Y, et al. Association between subcortical vascular lesion location and cognition: a voxel-based and tract-based lesion-symptom mapping study. The smart-mr study. PloS one. 2013;8:e60541.
40. Duering M, Gesierich B, Seiler S, et al. Strategic white matter tracts for processing speed deficits in age-related small vessel disease. Neurology. 2014;82:1946-1950.
41. Lawrence AJ, Chung AW, Morris RG, et al. Structural network efficiency is associated with cognitive impairment in small-vessel disease. Neurology. 2014;83:304-311.
42. Reijmer YD, Fotiadis P, Martinez-Ramirez S, et al. Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy. Brain. 2014. [Epub ahead of print].
43. Glymour MM, Chene G, Tzourio C, et al. Brain mri markers and dropout in a longitudinal study of cognitive aging: the three-city dijon study. Neurology. 2012;79:1340-1348.
44. Rodriguez BL, D'Agostino R, Abbott RD, et al. Risk of hospitalized stroke in men enrolled in the honolulu heart program and the framingham study: a comparison of incidence and risk factor effects. Stroke. 2002;33:230-236.
45. Rosamond WD, Folsom AR, Chambless LE, et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the atherosclerosis risk in communities (aric) cohort. Stroke. 1999;30:736-743.
46. Seshadri S, Wolf PA, Beiser A, et al. Stroke risk profile, brain volume, and cognitive function: the framingham offspring study. Neurology. 2004;63:1591-1599.
47. Das RR, Seshadri S, Beiser AS, et al. Prevalence and correlates of silent cerebral infarcts in the framingham offspring study. Stroke. 2008;39:2929-2935.